| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > MBA Research Project - Creativity, Innovation and Effective Teams |
|
Just Other Articles - MBA Research Project - Creativity, Innovation and Effective Teams
The right team structure is essential for a variety of endeavours. let alone According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product creativity and innovation. Defining creativity as problem identification and ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in idea generation and innovation as idea selection, development and commercial lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. isation, it becomes easy to see how team structures can vary according to the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe specific area of the creativity and innovation process. There are essential d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ly four possible structures: a) The single individual - many single individu ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc als have been known to make significant contributions in their fields - Einst easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ein etc. But can you separate the idea from its influences? Individuals also nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically suffer a high degree of path dependency. b) The pair. This structure goes so and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ me way to overcoming path dependencies but does not benefit from the intellec ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tual cross pollination of large groups. c) The small group. Intellectual cro ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ss pollination increases but so do core and peripheral information pathways, dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod creating hierarchies and restricting information flow. d) The large group. V cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ery high levels of intellectual cross pollination but an increase in group th tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ink, a decline in individual performance, higher evaluation apprehension, an t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel increase in political behaviour and more. In conclusion, it seems that a pai ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r and small group combinations are most effective overall. But different comb y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products inations geared for the specific endeavour produce the best results overall. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ********************************** You are free to reproduce this article a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Municipality Prefers Vertical File Storage Systems Questioning the Data of Demographic Off The Shelf Marketing Products How to Find Your True Vocation
|